Clinical trial
Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment…
NCT00355251 · Germans Trias i Pujol Hospital, Other · Terminated
Key facts
| NCT number | NCT00355251 |
|---|---|
| Title | Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption |
| Official title | Study of the Influence of Atorvastatin in Plasma Viral Replication Given Prior to Antiretroviral Treatment Interruption in Patients With HIV-1 Infection and Viral Suppression. |
| Lead sponsor | Germans Trias i Pujol Hospital, Other |
| Collaborators | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atorvastatin 40 mg/Atorvastatin 80 mg |
| Enrollment | 5 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Jul 21, 2006 |
| Last update posted | Mar 20, 2014 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: